Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery
Sponsor : Predictive Oncology
Deal Size : $1.8 million
Deal Type : Acquisition
Predictive Oncology Completes Acquisition of Quantitative Medicine
Details : Integrating QM’s proven machine learning platform, CoRE, with Predictive Oncology's proprietary database of drug response and genomics profiles is expected to revolutionize the role of its AI-driven predictive models in the discovery and development of...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
July 07, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery
Sponsor : Predictive Oncology
Deal Size : $1.8 million
Deal Type : Acquisition
Reset All
